Missing/wrong data?
Log in to edit
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
scientific article
Author/s
author: Sherene Loi, Stefan Michiels, Christine Desmedt, Carsten Denkert, Mark J. Smyth, Heikki Joensuu, Vinu Jose, Vesa Kataja, Sibylle Loibl, Pirkko-Liisa Kellokumpu-Lehtinen
Work details
Publication date
March 7, 2014
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.